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healthcare systems.2 This is noteworthy, since a
variety of additional variables may contribute
to adverse risk besides the elevation of cardiac
biomarkers and the presence of suggestive electro-
cardiogram changes.7,8 Our results support this
hypothesis, underlining that a strategy aimed at
rationalizing troponin testing, such as that proposed
by Ramsay et al., based on the application of a
validated risk assessment, would be far more cost-
effective for identifying patients at higher risk for
subsequent cardiac events, especially those present-
ing at the emergency department, than simply doing
an isolated troponin measurement at admission.2
With pressure from cost containment and
reimbursement policies worldwide, expenditure on
non-diagnostic results also highlights the need to
identify diagnostic strategies based on something
more concrete than simple clinical suspicion.
In addition, a positive troponin result in a patient
in whom the test was inappropriate in the first
instance, may generate other unfavourable conse-
quences, including decreased specificity, costs
and health risk from further investigations, and
unnecessary patient anxiety.9
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Estimated glomerular filtration rates
(eGFR): predicting progression is
dependent on accuracy
Sir,
In a recent paper, Hemmelgarn et al. introduced
a potentially important clinical risk score for the
prediction of progression amongst patients with
chronic kidney disease (CKD).1 The use of readily
available clinical data to allow risk stratification of
patients would represent a significant advance in
the practical management of CKD. However,
the study has a number of potentially problematic
methodological issues. The authors chose to
limit their study population to those with an eGFR
<90ml/min/1.73m2, because of concerns
regarding the validity of the MDRD eGFR estimate
above that level of function.2 These validity
concerns continue to be a problem when using the
MDRD estimation equation between 60 and 90ml/
min/1.73m2, and this concern has become so
prominent within the nephrology community that
the equation’s creators have recommended report-
ing eGFR estimates as simply460ml/min/1.73m2,
rather than giving specific estimates above
that level.3
Recent advances have improved the accuracy
of the MDRD equation (traceable by isotope
dilution mass spectrometry IDMS),4 but (as recently
discussed in QJM) these corrections are dependent
on central laboratory validation and provision of
correction factors.5 Regardless of the methodology,
there remains significant concern over the
clinical relevance of an estimated GFR between
60 and 90ml/min/1.73m2, particularly in the
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elderly female population. Including these
patients in the analysis increases the likelihood of
misclassifying anomalies in creatinine measurement
and eGFR estimation as progression. Previous
studies have indicated the potential variance of
eGFR estimation in the same person over time
within the same laboratory, and more recently we
have come to realize the impact of simple daily
activities, such as a cooked meal,6 on eGFR
estimations.
In epidemiological studies assessing CKD
progression, it is crucial to limit methodological
errors in creatinine measurement and eGFR estima-
tion, if we are to gain a reliable understanding of
the natural history of CKD.7,8 Cystatin C may
represent the most exciting potential solution to
estimating renal function accurately in early CKD,
but its expense and lack of availability currently
limit its use; until this changes, we must be aware of
the limitations of our currently used estimates.
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